Disease Progression in Papillary Thyroid Cancer with Biochemical Incomplete Response to Initial Therapy.

about

Disease Progression in Papillary Thyroid Cancer with Biochemical Incomplete Response to Initial Therapy.

Item

http://www.wikidata.org/entity/Q38741579

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Disease Progression in Papilla ...... e Response to Initial Therapy.

@en

type

Item

label

Disease Progression in Papilla ...... e Response to Initial Therapy.

@en

prefLabel

Disease Progression in Papilla ...... e Response to Initial Therapy.

@en

P1476

Disease Progression in Papilla ...... e Response to Initial Therapy.

@en

P2093

Ahmad Aniss

http://www.w3.org/2001/XMLSchema#string

Anthony J Gill

http://www.w3.org/2001/XMLSchema#string

Bruce Robinson

http://www.w3.org/2001/XMLSchema#string

Diana Learoyd

http://www.w3.org/2001/XMLSchema#string

Leigh Delbridge

http://www.w3.org/2001/XMLSchema#string

Mark Sywak

http://www.w3.org/2001/XMLSchema#string

Stan Sidhu

http://www.w3.org/2001/XMLSchema#string

P2860

BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence.

Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Associat

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.

Contemporary post surgical management of differentiated thyroid carcinoma.

Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy.

BRAF(V600E) Mutation is Associated with Decreased Disease-Free Survival in Papillary Thyroid Cancer.

Does BRAF V600E mutation predict aggressive features in papillary thyroid cancer? Results from four endocrine surgery centers.

P2888

s10434-017-5911-6

P304

2611-2616

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-017-5911-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roderick J Clifton-Bligh

Nicole K Zern

P577

2017-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085872615

http://www.w3.org/2001/XMLSchema#string

P698

28585075

http://www.w3.org/2001/XMLSchema#string